BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 19271427)

  • 1. [Acid related diseases progress in 2007].
    Vouillamoz D; Jornod P; Viani F; Nichita C; Dorta G
    Rev Med Suisse; 2008 Jan; 4(141):190, 192, 194 passim. PubMed ID: 18335884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Medical treatment efficient in chronic reflux. Also surgery has a given place in long-term therapy--for certain patients].
    Lundell L
    Lakartidningen; 2009 Feb 18-24; 106(8):502-5. PubMed ID: 19350782
    [No Abstract]   [Full Text] [Related]  

  • 3. [Progress in 2008 for acid related diseases].
    Jornod P; Vouillamoz D; Viani F; Nichita C; Dorta G
    Rev Med Suisse; 2009 Jan; 5(187):167-70, 172-5. PubMed ID: 19271427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy resistance of gastro-oesophageal reflux symptoms: acid reflux, non-acid reflux or no reflux].
    Bredenoord AJ; Smout AJ
    Ned Tijdschr Geneeskd; 2008 Nov; 152(47):2548-52. PubMed ID: 19174935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric ulcer treatment: cure of Helicobacter pylori infection without subsequent acid-suppressive therapy: is it effective?
    van Zanten SV; van der Knoop B
    Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):489-91. PubMed ID: 18467903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori eradication: role of individual therapy constituents and therapy duration.
    Qasim A; O'Morain CA; O'Connor HJ
    Fundam Clin Pharmacol; 2009 Feb; 23(1):43-52. PubMed ID: 19207543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment for patients with gastroesophageal reflux disease.
    Beck J
    Director; 2004; 12(1):25-7. PubMed ID: 19178114
    [No Abstract]   [Full Text] [Related]  

  • 8. Is there a dark side to long-term proton pump inhibitor therapy?
    Nealis TB; Howden CW
    Am J Ther; 2008; 15(6):536-42. PubMed ID: 19127138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis used to identify factors associated with the effectiveness of proton pump inhibitors against non-erosive reflux disease.
    Hiyama T; Matsuo K; Urabe Y; Fukuhara T; Tanaka S; Yoshihara M; Haruma K; Chayama K
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1326-32. PubMed ID: 19702900
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.